1. Diagnostic Solution – MMPA Panel Discussion
To change this title, go to Notes Master
4/11/2018
Diagnostic Solution – MMPA Panel Discussion
Dr. Ayaskant Pany

2. Q 2 LAB Pretoria, South Africa
Established in 1999; CAP Accredited since 1999; First CAP accredited lab on the African continent; Only CAP accredited lab in South Africa.
New facility inaugurated in Q
CAP15189 Accredited – First time successful – Oct 2014; Surveillance assessment 1 – completed Sep 2015.
Certifications – CDC Lipids Certification; NGSP, Level 1
Number of employees: 47 + support functions
Full Service laboratory facility services:
Pre-analytical (Sample accessioning)
Analytical (Safety and Esoteric)
Project Services (Project management)
Specimen Management and Storage (Ambient
and Frozen)
Clinic supplies (Kit building)
Logistics Support

3. A range of scientific methodologies
Central Labs
4/11/2018
Our broad range of capabilities support scientific advancement through multiple assays and tests. Our constantly expanding test menu includes more than 400 tests and assays, with capabilities in a full range of laboratory science disciplines, methods, instruments and therapeutic targets.

4. Spotlight on Tuberculosis
A Full Array of Research Based TB Testing Capabilities
‘ONE STOP SHOP’
The Q2 Advantage in TB Testing
Smear—conventional ZN and Fluorescent staining
Culture, Identification, and Susceptibility (1st and 2nd line) – BD MGIT™ system as well as on LJ medium.
HAINs assays - Genotypic drug resistance and Speciation.
GeneXpert® system
QuantiFERON®- TB Gold test
Advanced immunological assays, e.g., ELISPOT
MIC determination and New drug susceptibility
Client specific ‘customized’ assays.
All TB related testing in a single facility
State-of-the-art biosafety labs
Dedicated BSL3 level lab for all TB isolation

6. Tuberculosis
Visit Schedule

7. Q2 Tailored Solution One-size does not fit-all
Focused on the 4 high risk disease areas as agreed
HIV TB
Hypertension
Diabetes
We reviewed the requirements outlined in the NDoH guidelines for each therapeutic area and converted it into a structured protocol schedule which would be used to set up the Sibanye dedicated database. The below guidelines were used and testing applied accordingly
TB investigations Reference – National TB management 2014 Guidelines; Released by the Department of Health; Compiled by - TB DOTS Strategy Coordination, National Department of Health.
HIV investigations Reference - THE SOUTH AFRICAN ANTIRETROVIRAL TREATMENT GUIDELINES, Released by the Department of Health. VERSION 14 March 2013
Diabetes investigations Reference - The 2012 SEMDSA Guideline for the Management of Type 2 Diabetes (Revised); JEMDSA 2012 Volume 17 Number 2 (Supplement 1) Page S1-S95
Hypertension investigations Reference – South African hypertension practice guideline 2014; CARDIOVASCULAR JOURNAL OF AFRICA • Volume 25, No 6, November/December
General Reference - PRIMARY CARE 101 GUIDELINE 2013/14; Commissioned and published by: The National Department of Health Private Bag x828 Pretoria Developed by the University of Cape Town Lung Institute for the NDoH.

8. HIV
Testing Schedule

9. Q2 Solutions patient-centric services
To change this title, go to Notes Master
4/11/2018
Services, assay, and technology that put the patient first
Sibanye Mine Clinic
Sample collection
Client dedicated database
Shipment to Q2 testing Lab (Pretoria)
Result reporting
Sample management
Project
Manager
TESTING:
Diabetes, Hypertension, HIV, TB
Other analytical tests